The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Formulation Comprising A Mek Inhibitor - EP3702351

The patent EP3702351 was granted to Array Biopharma on Nov 22, 2023. The application was originally filed on Oct 18, 2013 under application number EP19211405A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3702351

ARRAY BIOPHARMA
Application Number
EP19211405A
Filing Date
Oct 18, 2013
Status
Granted And Under Opposition
Oct 20, 2023
Publication Date
Nov 22, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBAug 21, 2024TER MEER STEINMEISTER & PARTNERADMISSIBLE
STADA ARZNEIMITTELAug 2, 2024HAMM & WITTKOPPADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO03077914
OPPOSITIONEP1797881
OPPOSITIONEP2909182
OPPOSITIONEP3702351
OPPOSITIONWO03077914
OPPOSITIONWO2012145503
OPPOSITIONWO2013033133
OPPOSITIONWO2014063024
SEARCHWO03077914
SEARCHWO2007076245

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents